NEW & EFFECTIVE IMMEDIATELY: When is the new Certification and demonstration of MPPP enrollment and/or ICPAP denial required for Medicare Part D/Medicare Advantage patients?

All Medicare Part D/Medicare Advantage enrollees seeking access to the Pfizer Patient Assistance Program for the 2025 enrollment year, must attest to and provide evidence of their enrollment in the Medicare Prescription Payment Plan. In addition, patients must apply to all applicable ICPAPs and continue to provide proof of ICPAP denial, from each before being considered for PAP. These requirements will immediately be applied to all 2025 enrollment form submissions.

To demonstrate proof of MPPP enrollment, patients can provide a paper letter or email confirmation, or screen shot of enrollment. Missing proof of enrollment in MPPP will prevent the enrollment form from being processed for patients with an annual pre-tax household income above 138% of the FPL.

To demonstrate proof of denial from all ICPAPs to which a patient was referred, patients should include a paper or email notification, or screen shot of the denial from the ICPAP(s) indicating their denial for support. In certain circumstances, if the ICPAP does not provide written documentation, we will accept a patient’s verbal confirmation that they were denied along with the reason for denial. Applications will not be processed until/unless the documentation is received.